Back to company

PROXEON BIOSYSTEMS ApS: Financial statements 2021

CVR: 26848024

PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 30,910,000 and a net result of DKK 23,932,000 compared with DKK 15,661,000 the year before. That is an increase of 49.1% compared with the year before. Equity amounted to DKK 356,976,000. The solvency ratio was 98.1%.

Gross Profit
30,910,000 kr.
Profit/Loss
23,932,000 kr.
Equity
356,976,000 kr.
Total Assets
363,853,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-30.9 mio.23.9 mio.357 mio.-
2020-20.7 mio.15.7 mio.333 mio.-
2019-42 mio.32.3 mio.317.4 mio.-
2018-47.7 mio.36.2 mio.285.1 mio.-
2017-38 mio.29.5 mio.248.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PROXEON BIOSYSTEMS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

PROXEON BIOSYSTEMS ApS: The 2020 annual report is outJun 30, 2021

PROXEON BIOSYSTEMS ApS has published its annual report for 2020. Gross profit came to DKK 20,729,000, and the net result was DKK 15,661,000.

About PROXEON BIOSYSTEMS ApS

PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The company is owned by NUNC A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity amounted to DKK 386,590,000.